Xiaoying Lu, Ph.D.
Affiliations: | University of Southern California, Los Angeles, CA, United States |
Area:
glutamate receptors, LTP, neurodegeneration, calpainGoogle:
"Xiaoying Lu"Mean distance: 15.9 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentor| Michel Baudry | grad student | 2001 | USC | |
| (Biochemical evidence for calpain's involvement in long term synaptic plasticity.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Li Y, Li X, Sun WK, et al. (2015) Comparison of liver microRNA transcriptomes of Tibetan and Yorkshire pigs by deep sequencing. Gene |
| Liao WQ, Qi YL, Wang L, et al. (2015) Recql5 protects against lipopolysaccharide/D-galactosamine-induced liver injury in mice. World Journal of Gastroenterology : Wjg. 21: 10375-84 |
| Bajo M, Madamba SG, Lu X, et al. (2012) Receptor subtype-dependent galanin actions on gamma-aminobutyric acidergic neurotransmission and ethanol responses in the central amygdala. Addiction Biology. 17: 694-705 |
| Mitsukawa K, Lu X, Bartfai T. (2010) Galanin, galanin receptors, and drug targets. Experientia. Supplementum. 102: 7-23 |
| Lu X, Roberts E, Xia F, et al. (2010) GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models. Proceedings of the National Academy of Sciences of the United States of America. 107: 15229-34 |
| Mitsukawa K, Lu X, Bartfai T. (2009) Bidirectional regulation of stress responses by galanin in mice: Involvement of galanin receptor subtype 1 Neuroscience. 160: 837-846 |
| Lu X, Bartfai T. (2009) Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 379: 417-20 |
| Lu X, Ross B, Sanchez-Alavez M, et al. (2008) Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests. Neuropeptides. 42: 387-97 |
| Lu X, Sharkey L, Bartfai T. (2007) The brain galanin receptors: targets for novel antidepressant drugs. Cns & Neurological Disorders Drug Targets. 6: 183-92 |
| Conti B, Maier R, Barr AM, et al. (2007) Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Molecular Psychiatry. 12: 167-89 |